Related Experiment Video
Updated: Jun 13, 2025

Generation of Oligodendrocytes and Oligodendrocyte-Conditioned Medium for Co-Culture Experiments
Published on: February 9, 2020
Oligodendrocyte and Myelin Pathophysiology in Multiple Sclerosis
Eneritz López-Muguruza1,2, Carla Peiró-Moreno1,2, Asier Ruiz3
1Department of Neurosciences, University of the Basque Country UPV/EHU, IIS-BioBizkaia and CIBERNED, Leioa, Spain.
Abstract:
Multiple sclerosis (MS) is a chronic autoimmune and progressive neurodegenerative disease of the central nervous system (CNS) that has a highly variable clinical manifestation and course. MS targets primarily myelin and oligodendroglia; however, all glial cells and neurons become involved early in the pathology. Thus, inflammation, which is widely thought to be initiated peripherally, expands through the CNS, with astrocytes and microglia entering an activated state not only around and within lesions but also widespread. This chapter will emphasize the pathophysiological changes in oligodendrocytes and myelin as a consequence of the inflammatory cascade driving the disease onset and progression. Learning about the mechanisms of oligodendrocyte and myelin damage beyond the immune attack will be instrumental in protecting these two CNS compartments from damage. In turn, knowledge about the axon-myelin unit will help in devising therapies to prevent axonal degeneration, a key clinical hallmark of MS, as it strongly correlates with the progression of CNS atrophy and symptoms. Finally, exploiting paradigms of oligodendrocyte repopulation and remyelination will definitively contribute to devising treatments for tissue repair and halting MS course. This chapter aims at summarizing the state of the art in all these experimental developments including the available clinical therapies and the current clinical trials.
Insights
Multiple sclerosis (MS) is a progressive neurodegenerative disease targeting the central nervous system (CNS). Understanding oligodendrocyte and myelin damage is key to developing therapies for tissue repair and halting MS progression.
Area of Science:
- Neuroimmunology
- Neurodegeneration
- Central Nervous System Pathology
Background:
- Multiple sclerosis (MS) is a chronic, autoimmune, and progressive neurodegenerative disease affecting the central nervous system (CNS).
- MS pathology primarily targets myelin and oligodendrocytes, but also involves other glial cells and neurons.
- Inflammation, initiated peripherally, spreads throughout the CNS, activating astrocytes and microglia.
Purpose of the Study:
- To emphasize pathophysiological changes in oligodendrocytes and myelin due to the inflammatory cascade in MS.
- To explore mechanisms of oligodendrocyte and myelin damage beyond immune attack for CNS protection.
- To summarize experimental developments, clinical therapies, and trials for MS tissue repair and halting disease progression.
Main Methods:
- Review of current literature on MS pathophysiology.
- Analysis of inflammatory cascade mechanisms impacting CNS.
- Examination of oligodendrocyte repopulation and remyelination strategies.
Main Results:
- Inflammation drives oligodendrocyte and myelin damage in MS.
- Understanding the axon-myelin unit is crucial for preventing axonal degeneration.
- Oligodendrocyte repopulation and remyelination offer therapeutic potential.
Conclusions:
- Targeting oligodendrocyte and myelin pathology is essential for MS treatment.
- Preventing axonal degeneration is critical for managing MS symptoms and CNS atrophy.
- Further research into remyelination strategies holds promise for halting MS progression.
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Glial Cells
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Parkinson's Disease: Overview

